58,742 Shares in Synopsys, Inc. $SNPS Bought by Munich Reinsurance Co Stock Corp in Munich

Munich Reinsurance Co Stock Corp in Munich acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 58,742 shares of the semiconductor company’s stock, valued at approximately $28,983,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Stanley Laman Group Ltd. raised its position in Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after acquiring an additional 10,874 shares during the period. Symphony Financial Ltd. Co. increased its stake in shares of Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares in the last quarter. Empirical Asset Management LLC purchased a new stake in shares of Synopsys in the 3rd quarter worth $773,000. Strategic Advisors LLC raised its holdings in Synopsys by 76.3% in the 3rd quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock worth $3,739,000 after purchasing an additional 3,279 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd lifted its position in Synopsys by 17.6% during the second quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 23,683 shares of the semiconductor company’s stock valued at $12,142,000 after purchasing an additional 3,544 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $437.41 on Friday. The company has a market cap of $83.79 billion, a P/E ratio of 67.92, a P/E/G ratio of 3.60 and a beta of 1.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The firm’s fifty day moving average is $466.71 and its two-hundred day moving average is $470.69.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. During the same quarter in the prior year, the firm earned $3.03 EPS. The business’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Activity at Synopsys

In other Synopsys news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last 90 days. 0.56% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. JPMorgan Chase & Co. boosted their price objective on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Wells Fargo & Company lowered their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a report on Thursday, February 26th. Finally, KeyCorp upped their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $531.00.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.